MedPath

NUBAIN INJECTION 20MG/ML

NUBAIN INJECTION 20MG/ML

Discontinued
DIN Number

01913972

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01913972
AIG Number0114464002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
N02AF02 NALBUFINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Subcutaneous ,  Intravenous
AHFS Classification28:08.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

NALBUPHINE HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: NALBUPHINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.